Mark A Stein, PHD, ABPP

Mark A Stein, PHD, ABPP

Psychiatry and Behavioral Medicine

On staff since April 2013

Children's Title: Director, ADHD and Related Disorders Program (PEARL Clinic)

Research Center: Center for Child Health, Behavior and Development

"I first became interested in ADHD and stimulant medications when I was a camp counselor of 12, 7-year old boys. One of my exuberant campers, would chase butterflies but would not play kickball or follow directions. One day, he seemed very different. That day, he followed the rules of the game, and even scored a run. His personality was different also, more serious and quiet , and he had no appetite for lunch. Having spent the last 30 years studying ADHD treatment effects, both positive and negative, I want to spend the next 10 learning how to sequence and deliver individualized treatments for the impairments related to ADHD and to train others who see children, adolescents, and adults in managing this commonly misunderstood disorder."

  • Mark A. Stein, Ph.D., ABPP, is the director of PEARL Clinic/ADHD and Related Disorders Program at Seattle Childrens Hospital and an investigator at Seattle Childrens Research Institute. He is also a professor of psychiatry and behavioral science and a professor of pediatrics at the University of Washington.

    Dr. Stein currently serves as the President of the American Professional Society of ADHD and Related Disorders (APSARD). He is also a member of the American Society of Clinical Psychopharmacology, the Society for Pediatric Research, the Society of Behavioral Pediatrics, the Society of Biological Psychiatry, the International Sleep Medicine Society, the International Society of Pharmacogenomics, and the International Society for Research in Child and Adolescent Psychopathology (ISRCAP).

    Dr. Stein received his B.A. from Bowling Green State University and his M.A. and Ph.D from Southern Illinois University. He had an internship with the UCLA Neuropsychiatric Institute and a fellowship with the University of Chicago, Dept. Of Medicine. He has received many honors for his work, including being named a Fellow for the American Psychological Association, Division of Clinical Psychology, a Charter Fellow for the Society of Clinical Child and Adolescent Psychology, and a Diplomate in Clinical Psychology, American Board of Professional Psychology.

    • Related Pages

    • Improving Treatment for ADHD

      Dr. Mark Stein’s passion for helping children with attention deficit hyperactivity disorder (ADHD) started three decades ago when, working as a camp counselor, he witnessed how stimulant medications affect kids – for better and for worse.

    • Gina San Francisco 12.10.14

      I am a huge fan of Dr. Stein's published research and other writing. The field of ADHD is extremely lucky to have him.

    • Anna Chicago, Il 04.29.13

      Dr. Stein is equal parts compassionate and knowledgeable. He is very comfortable chatting with children in an age appropriate manner, and he is equally adroit in communicating with parents. There is the old saying, about loss and gain. When Dr. Stein (understandably went to Seattle Children's) Chicago's loss, Seattle's gain.

  • Award Name Award Description Awarded By Award Date
    Fellow Society of Clinical Child and Adolescent Psychology 2001
    Fellow in recognition of outstanding and unusual contributions to the science and profession of psychology American Psychological Association 2000
  • Manuscripts in Refereed Journals

    • Stein, M
      The War on ADHD
      Nature Medicine, 2013 : 19(12)1366

    Published Books, Videos, Software, etc.

    • Accardo, P., Blondis, T., Whitman, B. & Stein, M.A.
      Attention Deficit Disorder and Hyperactivity in Children and Adults ( 2nd Edition). Marcel Dekker: New York. 736pp.
      1999

    Other Publications

    • Atkins MB, Jegede OA, Haas NB, McDermott DF, Bilen MA, Stein M, Sosman JA, Alter R, Plimack ER, Ornstein M, Hurwitz M, Peace DJ, Signoretti S, Denize T, Cimadamore A, Wu CJ, Braun D, Einstein D, Catalano PJ, Hammers H
      Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A).
      35442713 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022 Sept. 1 : 40(25)2913-2923 PMCID:PMC9426835
    • Weiss MD, Stein MA
      Measurement Informed Care in Attention-Deficit/Hyperactivity Disorder (ADHD).
      35697390 Child and adolescent psychiatric clinics of North America, 2022 July : 31(3)363-372
    • Stein MA, Zulauf-McCurdy C, DelRosso LM
      Attention Deficit Hyperactivity Disorder Medications and Sleep.
      35697398 Child and adolescent psychiatric clinics of North America, 2022 July : 31(3)499-514
    • Stein MA
      Editorial Perspective: COVID-19, ADHD management and telehealth: uncertain path.
      35137959 Journal of child psychology and psychiatry, and allied disciplines, 2022 July : 63(7)829-831 PMCID:PMC9114980
    • Stein MA
      Editorial: Treating Attention-Deficit/Hyperactivity Disorder in Preschool-Age Children With Stimulants: Modest Effects in Young Children With Big Problems.
      35724816 Journal of the American Academy of Child and Adolescent Psychiatry, 2022 June 17
    • Stein MN, Fong L, Tutrone R, Mega A, Lam ET, Parsi M, Vangala S, Gutierrez AA, Haas NB
      ADXS31142 Immunotherapy ± Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I/II KEYNOTE-046 Study.
      35373299 The oncologist, 2022 June 8 : 27(6)453-461 PMCID:PMC9177110
    • Mamiya PC, Richards TL, Edden RAE, Lee AKC, Stein MA, Kuhl PK
      Reduced Glx and GABA Inductions in the Anterior Cingulate Cortex and Caudate Nucleus Are Related to Impaired Control of Attention in Attention-Deficit/Hyperactivity Disorder.
      35563067 International journal of molecular sciences, 2022 April 23 : 23(9) PMCID:PMC9100027
    • Wasserman RL, Gupta S, Stein M, Rabbat CJ, Engl W, Leibl H, Yel L
      Infection rates and tolerability of three different immunoglobulin administration modalities in patients with primary immunodeficiency diseases.
      34931880 Immunotherapy, 2022 March : 14(4)215-224
    • Sibley MH, Coxe SJ, Stein MA, Meinzer MC, Valente MJ
      Predictors of Treatment Engagement and Outcome Among Adolescents With Attention-Deficit/Hyperactivity Disorder: An Integrative Data Analysis.
      33865928 Journal of the American Academy of Child and Adolescent Psychiatry, 2022 Jan. : 61(1)66-79 PMCID:PMC9110034
    • Arnett AB, Rutter TM, Stein MA
      Neural Markers of Methylphenidate Response in Children With Attention Deficit Hyperactivity Disorder.
      35600991 Frontiers in behavioral neuroscience, 2022 : 16887622 PMCID:PMC9121006
    • Buitelaar J, Bölte S, Brandeis D, Caye A, Christmann N, Cortese S, Coghill D, Faraone SV, Franke B, Gleitz M, Greven CU, Kooij S, Leffa DT, Rommelse N, Newcorn JH, Polanczyk GV, Rohde LA, Simonoff E, Stein M, Vitiello B, Yazgan Y, Roesler M, Doepfner M, Banaschewski T
      Toward Precision Medicine in ADHD.
      35874653 Frontiers in behavioral neuroscience, 2022 : 16900981 PMCID:PMC9299434
    • Tan AR, Chan N, Kiesel BF, Stein MN, Moss RA, Malhotra J, Aisner J, Shah M, Gounder M, Lin H, Kane MP, Lin Y, Ji J, Chen A, Beumer JH, Mehnert JM
      A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies.
      34669023 Cancer chemotherapy and pharmacology, 2022 Jan. : 89(1)49-58 PMCID:PMC8934569
    • Norman S, Atabaki S, Atmore K, Biddle C, DiFazio M, Felten D, Fox E, Marschall D, Newman J, Robb A, Rowland C, Selekman R, Slovin A, Stein M, Strang J, Sable C
      Home direct-to-consumer telehealth solutions for children with mental health disorders and the impact of Covid-19.
      34923834 Clinical child psychology and psychiatry, 2022 Jan. : 27(1)244-258
    • Faraone SV, Banaschewski T, Coghill D, Zheng Y, Biederman J, Bellgrove MA, Newcorn JH, Gignac M, Al Saud NM, Manor I, Rohde LA, Yang L, Cortese S, Almagor D, Stein MA, Albatti TH, Aljoudi HF, Alqahtani MMJ, Asherson P, Atwoli L, Bölte S, Buitelaar JK, Crunelle CL, Daley D, Dalsgaard S, Döpfner M, Espinet S, Fitzgerald M, Franke B, Gerlach M, Haavik J, Hartman CA, Hartung CM, Hinshaw SP, Hoekstra PJ, Hollis C, Kollins SH, Sandra Kooij JJ, Kuntsi J, Larsson H, Li T, Liu J, Merzon E, Mattingly G, Mattos P, McCarthy S, Mikami AY, Molina BSG, Nigg JT, Purper-Ouakil D, Omigbodun OO, Polanczyk GV, Pollak Y, Poulton AS, Rajkumar RP, Reding A, Reif A, Rubia K, Rucklidge J, Romanos M, Ramos-Quiroga JA, Schellekens A, Scheres A, Schoeman R, Schweitzer JB, Shah H, Solanto MV, Sonuga-Barke E, Soutullo C, Steinhausen HC, Swanson JM, Thapar A, Tripp G, van de Glind G, Brink WVD, Van der Oord S, Venter A, Vitiello B, Walitza S, Wang Y
      The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder.
      33549739 Neuroscience and biobehavioral reviews, 2021 Sept. : 128789-818 PMCID:PMC8328933
    • Margolin EJ, Pina Martina LA, Miles CH, Wenske S, McKiernan JM, DeCastro GJ, Hyams ES, Drake CG, Lim EA, Stein MN, Deutsch I, Anderson CB
      Telemedicine in management of genitourinary malignancies: Patient and physician perspectives.
      34092480 Urologic oncology, 2021 Aug. : 39(8)480-486
    • Ola C, Gonzalez E, Tran N, Sasser T, Kuhn M, LaCount PA, Stein MA, Mendoza JA, Tandon PS
      Evaluating the Feasibility and Acceptability of the Lifestyle Enhancement for ADHD Program.
      34128050 Journal of pediatric psychology, 2021 July 20 : 46(6)662-672 PMCID:PMC8291680
    • Yu EY, Petrylak DP, O'Donnell PH, Lee JL, van der Heijden MS, Loriot Y, Stein MN, Necchi A, Kojima T, Harrison MR, Hoon Park S, Quinn DI, Heath EI, Rosenberg JE, Steinberg J, Liang SY, Trowbridge J, Campbell M, McGregor B, Balar AV
      Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial.
      33991512 The Lancet. Oncology, 2021 June : 22(6)872-882
    • Denmeade SR, Wang H, Agarwal N, Smith DC, Schweizer MT, Stein MN, Assikis V, Twardowski PW, Flaig TW, Szmulewitz RZ, Holzbeierlein JM, Hauke RJ, Sonpavde G, Garcia JA, Hussain A, Sartor O, Mao S, Cao H, Fu W, Wang T, Abdallah R, Lim SJ, Bolejack V, Paller CJ, Carducci MA, Markowski MC, Eisenberger MA, Antonarakis ES
      TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer.
      33617303 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021 April 20 : 39(12)1371-1382 PMCID:PMC8274807
    • Kapoor V, Ferri R, Stein MA, Ruth C, Reed J, DelRosso LM
      Restless sleep disorder in children with attention-deficit/hyperactivity disorder.
      33155540 Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021 April 1 : 17(4)639-643 PMCID:PMC8020699
    • Chalfin HJ, Pramparo T, Mortazavi A, Niglio SA, Schonhoft JD, Jendrisak A, Chu YL, Richardson R, Krupa R, Anderson AKL, Wang Y, Dittamore R, Pal SK, Lara PN, Stein MN, Quinn DI, Steinberg SM, Cordes LM, Ley L, Mallek M, Sierra Ortiz O, Costello R, Cadena J, Diaz C, Gulley JL, Dahut WL, Streicher H, Wright JJ, Trepel JB, Bottaro DP, Apolo AB
      Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer.
      33262136 Clinical cancer research : an official journal of the American Association for Cancer Research, 2021 March 1 : 27(5)1391-1398 PMCID:PMC7925349
    • Lam H, McNeil LK, Starobinets H, DeVault VL, Cohen RB, Twardowski P, Johnson ML, Gillison ML, Stein MN, Vaishampayan UN, DeCillis AP, Foti JJ, Vemulapalli V, Tjon E, Ferber K, DeOliveira DB, Broom W, Agnihotri P, Jaffee EM, Wong KK, Drake CG, Carroll PM, Davis TA, Flechtner JB
      An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor Growth.
      33504579 Cancer discovery, 2021 March : 11(3)696-713
    • Pal SK, Tangen C, Thompson IM Jr, Balzer-Haas N, George DJ, Heng DYC, Shuch B, Stein M, Tretiakova M, Humphrey P, Adeniran A, Narayan V, Bjarnason GA, Vaishampayan U, Alva A, Zhang T, Cole S, Plets M, Wright J, Lara PN Jr
      A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial.
      33592176 Lancet (London, England), 2021 Feb. 20 : 397(10275)695-703 PMCID:PMC8687736
    • Mamiya PC, Arnett AB, Stein MA
      Precision Medicine Care in ADHD: The Case for Neural Excitation and Inhibition.
      33450814 Brain sciences, 2021 Jan. 13 : 11(1) PMCID:PMC7828220
    • Apolo AB, Nadal R, Girardi DM, Niglio SA, Ley L, Cordes LM, Steinberg SM, Sierra Ortiz O, Cadena J, Diaz C, Mallek M, Davarpanah NN, Costello R, Trepel JB, Lee MJ, Merino MJ, Bagheri MH, Monk P, Figg WD, Gulley JL, Agarwal PK, Valera V, Chalfin HJ, Jones J, Streicher H, Wright JJ, Ning YM, Parnes HL, Dahut WL, Bottaro DP, Lara PN Jr, Saraiya B, Pal SK, Stein MN, Mortazavi A
      Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors.
      32915679 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020 Nov. 1 : 38(31)3672-3684 PMCID:PMC7605393
    • Tabakin AL, Stein MN, Anderson CB, Drake CG, Singer EA
      Cytoreductive nephrectomy for metastatic renal cell carcinoma, the ultimate urologic 'Choosing Wisely' campaign: a narrative review.
      33354523 Translational cancer research, 2020 Nov. : 9(11)7337-7349 PMCID:PMC7751973
    • Chronis-Tuscano A, French W, Strickland J, Sasser T, Gonzalez ENS, Whitlock KB, Stein MA
      Acute Effects of Parent Stimulant Medication Versus Behavioral Parent Training on Mothers' ADHD, Parenting Behavior, and At-Risk Children.
      32926603 The Journal of clinical psychiatry, 2020 Sept. 8 : 81(5)
    • Stein MN, Goodin S, Gounder M, Gibbon D, Moss R, Portal D, Lindquist D, Zhao Y, Takebe N, Tan A, Aisner J, Lin H, Ready N, Mehnert JM
      A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors.
      31388792 Investigational new drugs, 2020 June : 38(3)855-865
    • Portal DE, Weiss RE, Wojtowicz M, Mansour A, Monken C, Mehnert JM, Aisner JA, Kane M, Nishioka J, Aisner S, Peters S, Stein MN, Kim IY, Mayer TM, Shih W, Gulley J, Streicher H, Singer EA, Lattime EC
      Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinoma.
      31222182 Cancer gene therapy, 2020 June : 27(6)438-447 PMCID:PMC6923616
    • Russell D, Stein MA
      Seizure risk, methylphenidate, and ADHD: reassuring news.
      32450119 The Lancet. Child & adolescent health, 2020 June : 4(6)409-410
    • Tan XL, E JY, Lin Y, Rebbeck TR, Lu SE, Shang M, Kelly WK, D'Amico A, Stein MN, Zhang L, Jang TL, Kim IY, Demissie K, Ferrari A, Lu-Yao G
      Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer.
      32035002 Cancer medicine, 2020 April : 9(7)2379-2389 PMCID:PMC7131852
    • Hawley JE, Pan S, Figg WD, Lopez-Bujanda ZA, Strope JD, Aggen DH, Dallos MC, Lim EA, Stein MN, Hu J, Drake CG
      Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy.
      31899823 The Prostate, 2020 March : 80(4)336-344 PMCID:PMC6980998
    • Graff JN, Stein MN, Surana R, Al Rabadi L, Liu E, Fong L, Bailey S, Latour E, Newby TA, Moran AE, Beer TM
      Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation Therapy.
      32850444 Frontiers in oncology, 2020 : 101381 PMCID:PMC7426513
    • Lim I, Lindenberg ML, Mena E, Verdini N, Shih JH, Mayfield C, Thompson R, Lin J, Vega A, Mallek M, Cadena J, Diaz C, Mortazavi A, Knopp M, Wright C, Stein M, Pal S, Choyke PL, Apolo AB
      18F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab.
      31522271 European journal of nuclear medicine and molecular imaging, 2020 Jan. : 47(1)178-184 PMCID:PMC6885023
    • Sleasman JW, Lumry WR, Hussain I, Wedner HJ, Harris JB, Courtney KL, Mondou E, Lin J, Stein MR
      Immune globulin subcutaneous, human - klhw 20% for primary humoral immunodeficiency: an open-label, Phase III study.
      31621458 Immunotherapy, 2019 Nov. : 11(16)1371-1386
    • Mehnert JM, Kaveney AD, Malhotra J, Spencer K, Portal D, Goodin S, Tan AR, Aisner J, Moss RA, Lin H, Bertino JR, Gibbon D, Doyle LA, White EP, Stein MN
      A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors.
      31463691 Cancer chemotherapy and pharmacology, 2019 Oct. : 84(4)899-907
    • Mastro KA, Flynn L, Preuster C, Summers-Gibson L, Stein MH
      The Effects of Anesthesia on the Pediatric Developing Brain: Strategies to Reduce Anesthesia Use in Pediatric MRI and Nursing's Role in Driving Patient Safety.
      31196698 Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses, 2019 Oct. : 34(5)900-910
    • Lee GT, Kim JH, Kwon SJ, Stein MN, Hong JH, Nagaya N, Billakanti S, Kim MM, Kim WJ, Kim IY
      Dihydrotestosterone Increases Cytotoxic Activity of Macrophages on Prostate Cancer Cells via TRAIL.
      31184711 Endocrinology, 2019 Sept. 1 : 160(9)2049-2060 PMCID:PMC6691685
    • Gupta S, Stein M, Hussain I, Paris K, Engl W, McCoy B, Rabbat CJ, Yel L
      Tolerability of Ig20Gly during onboarding in patients with primary immunodeficiency diseases.
      31228628 Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2019 Sept. : 123(3)271-279.e1
    • Yuh BE, Kwon YS, Shinder BM, Singer EA, Jang TL, Kim S, Stein MN, Mayer T, Ferrari A, Lee N, Parikh RR, Ruel N, Kim WJ, Horie S, Byun SS, Ahlering TE, Kim IY
      Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer.
      31485434 Prostate international, 2019 Sept. : 7(3)102-107 PMCID:PMC6713798
    • Synold TW, Plets M, Tangen CM, Heath EI, Palapattu GS, Mack PC, Stein MN, Meng MV, Lara P, Vogelzang NJ, Thompson IM, Ryan CW
      Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249).
      31763512 Kidney cancer (Clifton, Va.), 2019 Aug. 7 : 3(2)111-118 PMCID:PMC6864417
    • Faraone SV, Silverstein MJ, Antshel K, Biederman J, Goodman DW, Mason O, Nierenberg AA, Rostain A, Stein MA, Adler LA
      The Adult ADHD Quality Measures Initiative.
      30511593 Journal of attention disorders, 2019 Aug. : 23(10)1063-1078
    • Suez D, Kriván G, Jolles S, Stein M, Gupta S, Paris K, van Hagen PM, Brodszki N, Engl W, Leibl H, McCoy B, Yel L
      Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents.
      31268374 Immunotherapy, 2019 Aug. : 11(12)1057-1065
    • Russell D, Weiss M, Stein MA
      A Maximum Dose for Methylphenidate-How Much Is Too Much?
      31135823 JAMA pediatrics, 2019 July 1 : 173(7)621-622
    • Stein MA
      Editorial: Is Less Parent Training "Not Inferior" to More?
      30797039 Journal of the American Academy of Child and Adolescent Psychiatry, 2019 June : 58(6)565-566
    • Steingard R, Taskiran S, Connor DF, Markowitz JS, Stein MA
      New Formulations of Stimulants: An Update for Clinicians.
      31038360 Journal of child and adolescent psychopharmacology, 2019 June : 29(5)324-339 PMCID:PMC7207053
    • Tandon PS, Sasser T, Gonzalez ES, Whitlock KB, Christakis DA, Stein MA
      Physical Activity, Screen Time, and Sleep in Children With ADHD.
      31056020 Journal of physical activity & health, 2019 June 1 : 16(6)416-422
    • Stein MN, Malhotra J, Tarapore RS, Malhotra U, Silk AW, Chan N, Rodriguez L, Aisner J, Aiken RD, Mayer T, Haffty BG, Newman JH, Aspromonte SM, Bommareddy PK, Estupinian R, Chesson CB, Sadimin ET, Li S, Medina DJ, Saunders T, Frankel M, Kareddula A, Damare S, Wesolowsky E, Gabel C, El-Deiry WS, Prabhu VV, Allen JE, Stogniew M, Oster W, Bertino JR, Libutti SK, Mehnert JM, Zloza A
      Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration.
      31118108 Journal for immunotherapy of cancer, 2019 May 22 : 7(1)136 PMCID:PMC6532211
    • Schoenfelder EN, Chronis-Tuscano A, Strickland J, Almirall D, Stein MA
      Piloting a Sequential, Multiple Assignment, Randomized Trial for Mothers with Attention-Deficit/Hyperactivity Disorder and Their At-Risk Young Children.
      30950637 Journal of child and adolescent psychopharmacology, 2019 May : 29(4)256-267 PMCID:PMC6534090
    • Ferrari AC, Alumkal JJ, Stein MN, Taplin ME, Babb J, Barnett ES, Gomez-Pinillos A, Liu X, Moore D, DiPaola R, Beer TM
      Correction: Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer.
      30988096 Clinical cancer research : an official journal of the American Association for Cancer Research, 2019 April 15 : 25(8)2672
    • Haas NB, Appleman LJ, Stein M, Redlinger M, Wilks M, Xu X, Onorati A, Kalavacharla A, Kim T, Zhen CJ, Kadri S, Segal JP, Gimotty PA, Davis LE, Amaravadi RK
      Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell Carcinoma.
      30635337 Clinical cancer research : an official journal of the American Association for Cancer Research, 2019 April 1 : 25(7)2080-2087 PMCID:PMC8915191
    • Stein MN, Chen YH, Carducci MA, Hudes GR, Lerma PM, Tan WW, Dalune R, Rowland KM, Kuzel TM, DiPaola RS
      Phase II Trial of Eribulin in Patients With Metastatic Hormone Refractory Prostate Cancer: A Trial of the ECOG-ACRIN Cancer Research Group (E5805).
      30789412 American journal of clinical oncology, 2019 April : 42(4)375-381 PMCID:PMC7212786
    • Radadia KD, Farber NJ, Tabakin AL, Wang W, Patel HV, Polotti CF, Weiss RE, Elsamra SE, Kim IY, Singer EA, Stein MN, Mayer TM, Jang TL
      Effect of alvimopan on gastrointestinal recovery and length of hospital stay after retroperitoneal lymph node dissection for testicular cancer.
      30854207 Journal of clinical urology, 2019 March : 12(2)122-128 PMCID:PMC6402349
    • Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J, Mosquera JM, Sailer V, Bareja R, Romanel A, Gumpeni N, Sboner A, Dardenne E, Puca L, Prandi D, Rubin MA, Scher HI, Rickman DS, Demichelis F, Nanus DM, Ballman KV, Tagawa ST
      A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.
      30232224 Clinical cancer research : an official journal of the American Association for Cancer Research, 2019 Jan. 1 : 25(1)43-51 PMCID:PMC6320304
    • Ferrari AC, Alumkal JJ, Stein MN, Taplin ME, Babb J, Barnett ES, Gomez-Pinillos A, Liu X, Moore D, DiPaola R, Beer TM
      Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer.
      30224345 Clinical cancer research : an official journal of the American Association for Cancer Research, 2019 Jan. 1 : 25(1)52-63
    • Hurwitz ME, Markowski P, Yao X, Deshpande H, Patel J, Mortazavi A, Donadio A, Stein MN, Kelly WK, Petrylak DP, Mehnert JM
      Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell Carcinoma.
      30177237 Clinical genitourinary cancer, 2018 Dec. : 16(6)437-444.e6
    • Drake CG, Stein MN
      The Immunobiology of Kidney Cancer.
      30372396 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018 Oct. 29 : JCO2018792648
    • Jang TL, Patel N, Faiena I, Radadia KD, Moore DF, Elsamra SE, Singer EA, Stein MN, Eastham JA, Scardino PT, Lin Y, Kim IY, Lu-Yao GL
      Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer.
      30252932 Cancer, 2018 Oct. 15 : 124(20)4010-4022 PMCID:PMC6234085
    • Memtsoudis SG, Cozowicz C, Nagappa M, Wong J, Joshi GP, Wong DT, Doufas AG, Yilmaz M, Stein MH, Krajewski ML, Singh M, Pichler L, Ramachandran SK, Chung F
      Society of Anesthesia and Sleep Medicine Guideline on Intraoperative Management of Adult Patients With Obstructive Sleep Apnea.
      29944522 Anesthesia and analgesia, 2018 Oct. : 127(4)967-987 PMCID:PMC6135479
    • Krishnamurthy A, Dasari A, Noonan AM, Mehnert JM, Lockhart AC, Leong S, Capasso A, Stein MN, Sanoff HK, Lee JJ, Hansen A, Malhotra U, Rippke S, Gustafson DL, Pitts TM, Ellison K, Davis SL, Messersmith WA, Eckhardt SG, Lieu CH
      Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer.
      30042150 Cancer research, 2018 Sept. 15 : 78(18)5398-5407 PMCID:PMC6139073
    • Arnett A, Stein M
      Refining treatment choices for ADHD.
      30097391 The lancet. Psychiatry, 2018 Sept. : 5(9)691-692 PMCID:PMC7876993
    • Panda A, de Cubas AA, Stein M, Riedlinger G, Kra J, Mayer T, Smith CC, Vincent BG, Serody JS, Beckermann KE, Ganesan S, Bhanot G, Rathmell WK
      Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma.
      30135306 JCI insight, 2018 Aug. 23 : 3(16) PMCID:PMC6141170
    • Shinder BM, Shupe A, Lee GT, Stein MN, Kim IY, Singer EA
      Role of the androgen signaling axis in genitourinary malignancies.
      30701159 Translational cancer research, 2018 Aug. : 7(4)1135-1142 PMCID:PMC6349041
    • Werner TL, Sachdev J, Swisher EM, Gutierrez M, Kittaneh M, Stein MN, Xiong H, Dunbar M, Sullivan D, Komarnitsky P, McKee M, Tan AR
      Safety and pharmacokinetics of veliparib extended-release in patients with advanced solid tumors: a phase I study.
      29733524 Cancer medicine, 2018 June : 7(6)2360-2369 PMCID:PMC6010916
    • Wagner J, Kline CL, Zhou L, Campbell KS, MacFarlane AW, Olszanski AJ, Cai KQ, Hensley HH, Ross EA, Ralff MD, Zloza A, Chesson CB, Newman JH, Kaufman H, Bertino J, Stein M, El-Deiry WS
      Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment.
      29533922 The Journal of clinical investigation, 2018 June 1 : 128(6)2325-2338 PMCID:PMC5983321
    • Stein MS, Ward GJ, Butzkueven H, Kilpatrick TJ, Harrison LC
      Dysequilibrium of the PTH-FGF23-vitamin D axis in relapsing remitting multiple sclerosis; a longitudinal study.
      30134801 Molecular medicine (Cambridge, Mass.), 2018 May 30 : 24(1)27 PMCID:PMC6016878
    • Rosenberg JE, Hahn NM, Regan MM, Werner L, Alva A, George S, Picus J, Alter R, Balar A, Hoffman-Censits J, Grivas P, Lauer R, Guancial EA, Hoimes C, Sonpavde G, Albany C, Stein MN, Breen T, Jacobs C, Anderson K, Bellmunt J, Lalani AA, Pal S, Choueiri TK
      Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2).
      29765151 British journal of cancer, 2018 May : 118(11)1434-1441 PMCID:PMC5988804
    • Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H, Lopez-Gitlitz A, Trudel GC, Espina BM, Shu Y, Park YC, Rackoff WR, Yu MK, Small EJ, SPARTAN Investigators.
      Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
      29420164 The New England journal of medicine, 2018 April 12 : 378(15)1408-1418
    • Stein MA, Newcorn JH
      C. Keith Conners (1933-2017).
      29648850 The American psychologist, 2018 April : 73(3)292
    • Hussain M, Daignault-Newton S, Twardowski PW, Albany C, Stein MN, Kunju LP, Siddiqui J, Wu YM, Robinson D, Lonigro RJ, Cao X, Tomlins SA, Mehra R, Cooney KA, Montgomery B, Antonarakis ES, Shevrin DH, Corn PG, Whang YE, Smith DC, Caram MV, Knudsen KE, Stadler WM, Feng FY, Chinnaiyan AM
      Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012.
      29261439 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018 April 1 : 36(10)991-999 PMCID:PMC6075827
    • Froehlich TE, Becker SP, Nick TG, Brinkman WB, Stein MA, Peugh J, Epstein JN
      Sluggish Cognitive Tempo as a Possible Predictor of Methylphenidate Response in Children With ADHD: A Randomized Controlled Trial.
      29489078 The Journal of clinical psychiatry, 2018 March : 79(2) PMCID:PMC6558969
    • Panda A, Mehnert JM, Hirshfield KM, Riedlinger G, Damare S, Saunders T, Kane M, Sokol L, Stein MN, Poplin E, Rodriguez-Rodriguez L, Silk AW, Aisner J, Chan N, Malhotra J, Frankel M, Kaufman HL, Ali S, Ross JS, White EP, Bhanot G, Ganesan S
      Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer.
      29155997 Journal of the National Cancer Institute, 2018 March 1 : 110(3)316-320 PMCID:PMC6658862
    • Mehnert JM, Edelman G, Stein M, Camisa H, Lager J, Dedieu JF, Ghuysen AF, Sharma J, Liu L, LoRusso PM
      A phase I dose-escalation study of the safety and pharmacokinetics of a tablet formulation of voxtalisib, a phosphoinositide 3-kinase inhibitor, in patients with solid tumors.
      28417284 Investigational new drugs, 2018 Feb. : 36(1)36-44
    • Paller CJ, Zhou XC, Heath EI, Taplin ME, Mayer T, Stein MN, Bubley GJ, Pili R, Hudson T, Kakarla R, Abbas MM, Anders NM, Dowling D, King S, Bruns AB, Wagner WD, Drake CG, Antonarakis ES, Eisenberger MA, Denmeade SR, Rudek MA, Rosner GL, Carducci MA
      Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial.
      29113986 Clinical cancer research : an official journal of the American Association for Cancer Research, 2018 Jan. 15 : 24(2)306-315 PMCID:PMC5771949
    • Ramroop JR, Stein MN, Drake JM
      Impact of Phosphoproteomics in the Era of Precision Medicine for Prostate Cancer.
      29503809 Frontiers in oncology, 2018 : 828 PMCID:PMC5820335
    • Khiabanian H, Hirshfield KM, Goldfinger M, Bird S, Stein M, Aisner J, Toppmeyer D, Wong S, Chan N, Dhar K, Gheeya J, Vig H, Hadigol M, Pavlick D, Ansari S, Ali S, Xia B, Rodriguez-Rodriguez L, Ganesan S
      Inference of Germline Mutational Status and Evaluation of Loss of Heterozygosity in High-Depth, Tumor-Only Sequencing Data.
      30246169 JCO precision oncology, 2018 : 2018 PMCID:PMC6148761
    • Tabakin AL, Sadimin ET, Tereshchenko I, Kareddula A, Stein MN, Mayer T, Hirshfield KM, Kim IY, Tischfield J, DiPaola RS, Singer EA
      Correlation of Prostate Cancer CHD1 Status with Response to Androgen Deprivation Therapy: a Pilot Study.
      30714046 Journal of genitourinary disorders, 2018 : 2(1) PMCID:PMC6358174
    • Suez D, Stein M, Gupta S, Hussain I, Melamed I, Paris K, Darter A, Bourgeois C, Fritsch S, Leibl H, McCoy B, Gelmont D, Yel L
      Response to the Letter to the Editor Regarding "Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials".
      28875256 Journal of clinical immunology, 2017 Nov. : 37(8)739-740 PMCID:PMC5662656
    • Parikh RR, Kim S, Stein MN, Haffty BG, Kim IY, Goyal S
      Trends in active surveillance for very low-risk prostate cancer: do guidelines influence modern practice?
      28925011 Cancer medicine, 2017 Oct. : 6(10)2410-2418 PMCID:PMC5633554
    • Wasserman RL, Melamed IR, Stein MR, Jolles S, Norton M, Moy JN, GMX07 Study Group.
      Erratum to: Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency.
      28714047 Journal of clinical immunology, 2017 Aug. : 37(6)613 PMCID:PMC6707972
    • Stein MN, Bertino JR, Kaufman HL, Mayer T, Moss R, Silk A, Chan N, Malhotra J, Rodriguez L, Aisner J, Aiken RD, Haffty BG, DiPaola RS, Saunders T, Zloza A, Damare S, Beckett Y, Yu B, Najmi S, Gabel C, Dickerson S, Zheng L, El-Deiry WS, Allen JE, Stogniew M, Oster W, Mehnert JM
      First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid Tumors.
      28331050 Clinical cancer research : an official journal of the American Association for Cancer Research, 2017 Aug. 1 : 23(15)4163-4169 PMCID:PMC7595575
    • Kim SJ, Shonka S, French WP, Strickland J, Miller L, Stein MA
      Dose-Response Effects of Long-Acting Liquid Methylphenidate in Children with Attention Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD): A Pilot Study.
      28474229 Journal of autism and developmental disorders, 2017 Aug. : 47(8)2307-2313
    • Schulz KP, Bédard AV, Fan J, Hildebrandt TB, Stein MA, Ivanov I, Halperin JM, Newcorn JH
      Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine.
      28647012 Journal of the American Academy of Child and Adolescent Psychiatry, 2017 July : 56(7)602-609.e2
    • Chronis-Tuscano A, Wang CH, Woods KE, Strickland J, Stein MA
      Parent ADHD and Evidence-Based Treatment for Their Children: Review and Directions for Future Research.
      28025755 Journal of abnormal child psychology, 2017 April : 45(3)501-517 PMCID:PMC5357146
    • Wasserman RL, Melamed IR, Stein MR, Jolles S, Norton M, Moy JN, GMX07 Study Group.
      Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency.
      28316003 Journal of clinical immunology, 2017 April : 37(3)301-310 PMCID:PMC5487756
    • Aspeslagh S, Stein M, Bahleda R, Hollebecque A, Salles G, Gyan E, Fudio S, Extremera S, Alfaro V, Soto-Matos A, Soria JC
      Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas.
      27977433 Anti-cancer drugs, 2017 March : 28(3)341-349
    • Stein MN, Jang TL
      Reply to C.G. Drake.
      27870573 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017 Feb. : 35(4)471-472
    • Sasser T, Schoenfelder EN, Stein MA
      Targeting Functional Impairments in the Treatment of Children and Adolescents with ADHD.
      27943133 CNS drugs, 2017 Feb. : 31(2)97-107
    • O'Neil BH, Wallmark JM, Lorente D, Elez E, Raimbourg J, Gomez-Roca C, Ejadi S, Piha-Paul SA, Stein MN, Abdul Razak AR, Dotti K, Santoro A, Cohen RB, Gould M, Saraf S, Stein K, Han SW
      Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.
      29284010 PloS one, 2017 : 12(12)e0189848 PMCID:PMC5746232
    • Shinder BM, Rhee K, Farrell D, Farber NJ, Stein MN, Jang TL, Singer EA
      Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach.
      28620578 Frontiers in oncology, 2017 : 7107 PMCID:PMC5449498
    • Bansal N, Bartucci M, Yusuff S, Davis S, Flaherty K, Huselid E, Patrizii M, Jones D, Cao L, Sydorenko N, Moon YC, Zhong H, Medina DJ, Kerrigan J, Stein MN, Kim IY, Davis TW, DiPaola RS, Bertino JR, Sabaawy HE
      BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer.
      27307599 Clinical cancer research : an official journal of the American Association for Cancer Research, 2016 Dec. 15 : 22(24)6176-6191 PMCID:PMC5159329
    • Hirshfield KM, Tolkunov D, Zhong H, Ali SM, Stein MN, Murphy S, Vig H, Vazquez A, Glod J, Moss RA, Belyi V, Chan CS, Chen S, Goodell L, Foran D, Yelensky R, Palma NA, Sun JX, Miller VA, Stephens PJ, Ross JS, Kaufman H, Poplin E, Mehnert J, Tan AR, Bertino JR, Aisner J, DiPaola RS, Rodriguez-Rodriguez L, Ganesan S
      Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers.
      27566247 The oncologist, 2016 Nov. : 21(11)1315-1325 PMCID:PMC5189630
    • Heery CR, Madan RA, Stein MN, Stadler WM, Di Paola RS, Rauckhorst M, Steinberg SM, Marté JL, Chen CC, Grenga I, Donahue RN, Jochems C, Dahut WL, Schlom J, Gulley JL
      Samarium-153-EDTMP (Quadramet®) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trial.
      27486817 Oncotarget, 2016 Oct. 18 : 7(42)69014-69023 PMCID:PMC5340090
    • Suez D, Stein M, Gupta S, Hussain I, Melamed I, Paris K, Darter A, Bourgeois C, Fritsch S, Leibl H, McCoy B, Gelmont D, Yel L
      Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America.
      27582171 Journal of clinical immunology, 2016 Oct. : 36(7)700-12 PMCID:PMC5018260
    • Pal SK, Choueiri TK, Wang K, Khaira D, Karam JA, Van Allen E, Palma NA, Stein MN, Johnson A, Squillace R, Elvin JA, Chmielecki J, Yelensky R, Yakirevich E, Lipson D, Lin DI, Miller VA, Stephens PJ, Ali SM, Ross JS
      Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling.
      26149668 European urology, 2016 Sept. : 70(3)516-21
    • Cui R, Yue W, Lattime EC, Stein MN, Xu Q, Tan XL
      Targeting tumor-associated macrophages to combat pancreatic cancer.
      27191744 Oncotarget, 2016 Aug. 2 : 7(31)50735-50754 PMCID:PMC5226617
    • Wasserman RL, Melamed I, Stein MR, Engl W, Sharkhawy M, Leibl H, Puck J, Rubinstein A, Kobrynski L, Gupta S, Grant AJ, Ratnayake A, Richmond WG, Church J, Yel L, Gelmont D
      Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency.
      27220317 Journal of clinical immunology, 2016 Aug. : 36(6)571-82 PMCID:PMC4940441
    • Wasserman RL, Lumry W, Harris J 3rd, Levy R, Stein M, Forbes L, Cunningham-Rundles C, Melamed I, Kobayashi AL, Du W, Kobayashi R
      Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease.
      27324887 Journal of clinical immunology, 2016 Aug. : 36(6)590-9 PMCID:PMC4940435
    • Wasserman RL, Stein MR, Younger ME, Fatteh S, Haddad E
      20% subcutaneous immunoglobulin dosed biweekly for primary immunodeficiency.
      27236217 Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2016 July : 117(1)93-4
    • Chronis-Tuscano A, Wang CH, Strickland J, Almirall D, Stein MA
      Personalized Treatment of Mothers With ADHD and Their Young At-Risk Children: A SMART Pilot.
      26799502 Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53, 2016 July : 45(4)510-21 PMCID:PMC4930389
    • Stein MN, Jang TL
      Striving Toward a Cure for Prostate Cancer.
      27022121 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016 June 20 : 34(18)2075-8
    • McKay RR, Zurita AJ, Werner L, Bruce JY, Carducci MA, Stein MN, Heath EI, Hussain A, Tran HT, Sweeney CJ, Ross RW, Kantoff PW, Slovin SF, Taplin ME
      A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local Therapy.
      27044933 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016 June 1 : 34(16)1913-20 PMCID:PMC5321094
    • Mehnert JM, Panda A, Zhong H, Hirshfield K, Damare S, Lane K, Sokol L, Stein MN, Rodriguez-Rodriquez L, Kaufman HL, Ali S, Ross JS, Pavlick DC, Bhanot G, White EP, DiPaola RS, Lovell A, Cheng J, Ganesan S
      Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer.
      27159395 The Journal of clinical investigation, 2016 June 1 : 126(6)2334-40 PMCID:PMC4887167
    • Stein MA, Snyder SM, Rugino TA, Hornig M
      Commentary: Objective aids for the assessment of ADHD - further clarification of what FDA approval for marketing means and why NEBA might help clinicians. A response to Arns et al. (2016).
      27192956 Journal of child psychology and psychiatry, and allied disciplines, 2016 June : 57(6)770-1
    • Su Y, Yang L, Stein MA, Cao Q, Wang Y
      Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up.
      26779845 Journal of child and adolescent psychopharmacology, 2016 May : 26(4)362-71
    • Agarwal N, Machiels JP, Suárez C, Lewis N, Higgins M, Wisinski K, Awada A, Maur M, Stein M, Hwang A, Mosher R, Wasserman E, Wu G, Zhang H, Zieba R, Elmeliegy M
      Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer.
      27091421 The oncologist, 2016 May : 21(5)535-6 PMCID:PMC4861370
    • Becker SP, Pfiffner LJ, Stein MA, Burns GL, McBurnett K
      Sleep habits in children with attention-deficit/hyperactivity disorder predominantly inattentive type and associations with comorbid psychopathology symptoms.
      26922623 Sleep medicine, 2016 May : 21151-9 PMCID:PMC4889552
    • Scher HI, Morris MJ, Stadler WM, Higano C, Basch E, Fizazi K, Antonarakis ES, Beer TM, Carducci MA, Chi KN, Corn PG, de Bono JS, Dreicer R, George DJ, Heath EI, Hussain M, Kelly WK, Liu G, Logothetis C, Nanus D, Stein MN, Rathkopf DE, Slovin SF, Ryan CJ, Sartor O, Small EJ, Smith MR, Sternberg CN, Taplin ME, Wilding G, Nelson PS, Schwartz LH, Halabi S, Kantoff PW, Armstrong AJ, Prostate Cancer Clinical Trials Working Group 3.
      Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.
      26903579 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016 April 20 : 34(12)1402-18 PMCID:PMC4872347
    • Thakur MK, Heilbrun LK, Sheng S, Stein M, Liu G, Antonarakis ES, Vaishampayan U, Dzinic SH, Li X, Freeman S, Smith D, Heath EI
      A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study.
      26581400 Investigational new drugs, 2016 Feb. : 34(1)112-8 PMCID:PMC6820516
    • Stein MN, Hussain M, Stadler WM, Liu G, Tereshchenko IV, Goodin S, Jeyamohan C, Kaufman HL, Mehnert J, DiPaola RS
      A Phase II Study of AT-101 to Overcome Bcl-2--Mediated Resistance to Androgen Deprivation Therapy in Patients With Newly Diagnosed Castration-Sensitive Metastatic Prostate Cancer.
      26476589 Clinical genitourinary cancer, 2016 Feb. : 14(1)22-7 PMCID:PMC4698193
    • Amin M, Minton SE, LoRusso PM, Krishnamurthi SS, Pickett CA, Lunceford J, Hille D, Mauro D, Stein MN, Wang-Gillam A, Trull L, Lockhart AC
      A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors.
      26620496 Investigational new drugs, 2016 Feb. : 34(1)84-95 PMCID:PMC4806784
    • McNeel DG, Bander NH, Beer TM, Drake CG, Fong L, Harrelson S, Kantoff PW, Madan RA, Oh WK, Peace DJ, Petrylak DP, Porterfield H, Sartor O, Shore ND, Slovin SF, Stein MN, Vieweg J, Gulley JL
      The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma.
      28031820 Journal for immunotherapy of cancer, 2016 : 492 PMCID:PMC5170901
    • Stein MA, King BH
      Unequal Individual Risk and Potential Benefit Balanced by Benefits to the Population at Large in Autism Clinical Trials?
      26982936 The American journal of bioethics : AJOB, 2016 : 16(4)72-4
    • Stein MA
      Commentary: Does helping mothers with ADHD in multiplex families help children? Reflections on Jans et al. (2015).
      26768524 Journal of child psychology and psychiatry, and allied disciplines, 2015 Dec. : 56(12)1314-5
    • Stein MA, Shaffer M, Echo-Hawk A, Smith J, Stapleton A, Melvin A
      Research START: A Multimethod Study of Barriers and Accelerators of Recruiting Research Participants.
      26643413 Clinical and translational science, 2015 Dec. : 8(6)647-54 PMCID:PMC4753776
    • Vaishampayan U, Shevrin D, Stein M, Heilbrun L, Land S, Stark K, Li J, Dickow B, Heath E, Smith D, Fontana J
      Phase II Trial of Carboplatin, Everolimus, and Prednisone in Metastatic Castration-resistant Prostate Cancer Pretreated With Docetaxel Chemotherapy: A Prostate Cancer Clinical Trial Consortium Study.
      26375845 Urology, 2015 Dec. : 86(6)1206-11 PMCID:PMC6902637
    • Stein MA, Sikirica V, Weiss MD, Robertson B, Lyne A, Newcorn JH
      Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled Trial.
      26547425 CNS drugs, 2015 Nov. : 29(11)953-62 PMCID:PMC4653245
    • Cohen S, Chhokra R, Stein MH, Denny JT, Shah S, Mohiuddin A, Naftalovich R, Zhao R, Pashkova A, Rolleri N, Patel AG, Hunter-Fratzola CW
      Ropivacaine 0.025% mixed with fentanyl 3.0 μg/ml and epinephrine 0.5 μg/ml is effective for epidural patient-controlled analgesia after cesarean section.
      26702203 Journal of anaesthesiology, clinical pharmacology, 2015 Oct. : 31(4)471-7 PMCID:PMC4676235
    • DiPaola RS, Chen YH, Bubley GJ, Stein MN, Hahn NM, Carducci MA, Lattime EC, Gulley JL, Arlen PM, Butterfield LH, Wilding G
      A national multicenter phase 2 study of prostate-specific antigen (PSA) pox virus vaccine with sequential androgen ablation therapy in patients with PSA progression: ECOG 9802.
      25533418 European urology, 2015 Sept. : 68(3)365-71 PMCID:PMC4472612
    • Hammer R, Tennekoon M, Cooke GE, Gayda J, Stein MA, Booth JR
      Feedback associated with expectation for larger-reward improves visuospatial working memory performances in children with ADHD.
      26142072 Developmental cognitive neuroscience, 2015 Aug. : 1438-49 PMCID:PMC4536089
    • Bansal N, Mishra PJ, Stein M, DiPaola RS, Bertino JR
      Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells.
      26036314 Oncotarget, 2015 June 20 : 6(17)15321-31 PMCID:PMC4558154
    • Snyder SM, Rugino TA, Hornig M, Stein MA
      Integration of an EEG biomarker with a clinician's ADHD evaluation.
      25798338 Brain and behavior, 2015 April : 5(4)e00330 PMCID:PMC4356845
    • Gaedigk A, Freeman N, Hartshorne T, Riffel AK, Irwin D, Bishop JR, Stein MA, Newcorn JH, Jaime LK, Cherner M, Leeder JS
      SNP genotyping using TaqMan technology: the CYP2D6*17 assay conundrum.
      25788121 Scientific reports, 2015 March 19 : 59257 PMCID:PMC4365394
    • Stein MN, Hirshfield KM, Zhong H, Singer EA, Ali SM, Ganesan S
      Response to crizotinib in a patient with MET-mutant papillary renal cell cancer after progression on tivantinib.
      25457019 European urology, 2015 Feb. : 67(2)353-4 PMCID:PMC5500309
    • Koterba AP, Stein MR
      Initiation of immunoglobulin therapy by subcutaneous administration in immunodeficiency patients naive to replacement therapy.
      25535489 Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2015 : 11(1)63 PMCID:PMC4273447
    • Hammer R, Cooke GE, Stein MA, Booth JR
      Functional neuroimaging of visuospatial working memory tasks enables accurate detection of attention deficit and hyperactivity disorder.
      26509111 NeuroImage. Clinical, 2015 : 9244-52 PMCID:PMC4576365
    • Bédard AC, Stein MA, Halperin JM, Krone B, Rajwan E, Newcorn JH
      Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder.
      24942409 Journal of child psychology and psychiatry, and allied disciplines, 2014 June 19
    • Stein MA, Waldman I, Newcorn J, Bishop J, Kittles R, Cook EH Jr
      Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder.
      24813374 Journal of child and adolescent psychopharmacology, 2014 June : 24(5)238-44 PMCID:PMC4064733
    • Owens J, Gruber R, Brown T, Corkum P, Cortese S, O'Brien L, Stein M, Weiss M
      Future research directions in sleep and ADHD: report of a consensus working group.
      22982880 Journal of attention disorders, 2013 Oct. : 17(7)550-64
    • Newcorn JH, Stein MA, Childress AC, Youcha S, White C, Enright G, Rubin J
      Randomized, double-blind trial of guanfacine extended release in children with attention-deficit/hyperactivity disorder: morning or evening administration.
      23972694 Journal of the American Academy of Child and Adolescent Psychiatry, 2013 Sept. : 52(9)921-30
    • Cortese S, Brown TE, Corkum P, Gruber R, O'Brien LM, Stein M, Weiss M, Owens J
      Assessment and management of sleep problems in youths with attention-deficit/hyperactivity disorder.
      23880489 Journal of the American Academy of Child and Adolescent Psychiatry, 2013 Aug. : 52(8)784-96
    • Adler LA, Kroon RA, Stein M, Shahid M, Tarazi FI, Szegedi A, Schipper J, Cazorla P
      A translational approach to evaluate the efficacy and safety of the novel AMPA receptor positive allosteric modulator org 26576 in adult attention-deficit/hyperactivity disorder.
      22771238 Biological psychiatry, 2012 Dec. 1 : 72(11)971-7
    • Conrad KJ, Conrad KM, Mazza J, Riley BB, Funk R, Stein MA, Dennis ML
      Dimensionality, hierarchical structure, age generalizability, and criterion validity of the GAIN's Behavioral Complexity Scale.
      22545694 Psychological assessment, 2012 Dec. : 24(4)913-24
    • Chronis-Tuscano A, Stein MA
      Pharmacotherapy for parents with attention-deficit hyperactivity disorder (ADHD): impact on maternal ADHD and parenting.
      22647070 CNS drugs, 2012 Sept. 1 : 26(9)725-32
    • Spruyt K, Raubuck DL, Grogan K, Gozal D, Stein MA
      Variable sleep schedules and outcomes in children with psychopathological problems: preliminary observations.
      23616725 Nature and science of sleep, 2012 : 49-17 PMCID:PMC3630967
    • Stein M, Weiss M, and Hlavaty, L.
      ADHD Treatments, Sleep, and Sleep Problems: Complex Associations
      Neurotherapeutics, 2012 : 9509-517
    • Stein MA, Waldman ID, Charney E, Aryal S, Sable C, Gruber R, Newcorn JH
      Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts.
      22136094 Journal of child and adolescent psychopharmacology, 2011 Dec. : 21(6)581-8 PMCID:PMC3243461
    • Froehlich TE, Epstein JN, Nick TG, Melguizo Castro MS, Stein MA, Brinkman WB, Graham AJ, Langberg JM, Kahn RS
      Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.
      22024001 Journal of the American Academy of Child and Adolescent Psychiatry, 2011 Nov. : 50(11)1129-1139.e2 PMCID:PMC3225067
    • Shook D, Brady C, Lee PS, Kenealy L, Murphy ER, Gaillard WD, VanMeter JW, Cook EH Jr, Stein M, Vaidya CJ
      Effect of dopamine transporter genotype on caudate volume in childhood ADHD and controls.
      20957668 American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2011 Jan. : 156B(1)28-35 PMCID:PMC3010298
    • Stollstorff M, Foss-Feig J, Cook EH Jr, Stein MA, Gaillard WD, Vaidya CJ
      Neural response to working memory load varies by dopamine transporter genotype in children.
      20053379 NeuroImage, 2010 Nov. 15 : 53(3)970-7 PMCID:PMC2888738
    • Newcorn JH, Stein MA, Cooper KM
      Dose-response characteristics in adolescents with attention-deficit/hyperactivity disorder treated with OROS methylphenidate in a 4-week, open-label, dose-titration study.
      20578931 Journal of child and adolescent psychopharmacology, 2010 June : 20(3)187-96
    • Lee SH, Shin DW, Stein MA
      Increased cortisol after stress is associated with variability in response time in ADHD children.
      20191011 Yonsei medical journal, 2010 March : 51(2)206-11 PMCID:PMC2824865
    • Froehlich TE, McGough JJ, Stein MA
      Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.
      20088618 CNS drugs, 2010 Feb. : 24(2)99-117 PMCID:PMC2874888
    • Froehlich TE, McGough JJ, Stein MA
      Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.
      20088618 CNS drugs, 2010 Feb. : 24(2)99-117 PMCID:PMC2874888
    • Chronis-Tuscano A, Rooney M, Seymour KE, Lavin HJ, Pian J, Robb A, Efron L, Conlon C, Stein MA
      Effects of maternal stimulant medication on observed parenting in mother-child dyads with attention-deficit/hyperactivity disorder.
      20589568 Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53, 2010 : 39(4)581-7
    • Chronis-Tuscano A, Rooney M, Seymour KE, Lavin HJ, Pian J, Robb A, Efron L, Conlon C, Stein MA
      Effects of maternal stimulant medication on observed parenting in mother-child dyads with attention-deficit/hyperactivity disorder.
      20589568 Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53, 2010 : 39(4)581-7
    • Hahn MK, Steele A, Couch RS, Stein MA, Krueger JJ
      Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorder.
      19698724 Neuropharmacology, 2009 Dec. : 57(7-8)694-701 PMCID:PMC2801604
    • Hahn MK, Steele A, Couch RS, Stein MA, Krueger JJ
      Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorder.
      19698724 Neuropharmacology, 2009 Dec. : 57(7-8)694-701 PMCID:PMC2801604
    • English BA, Hahn MK, Gizer IR, Mazei-Robison M, Steele A, Kurnik DM, Stein MA, Waldman ID, Blakely RD
      Choline transporter gene variation is associated with attention-deficit hyperactivity disorder.
      21547719 Journal of neurodevelopmental disorders, 2009 Dec. : 1(4)252-63 PMCID:PMC3164006
    • Gruber R, Joober R, Grizenko N, Leventhal BL, Cook EH Jr, Stein MA
      Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.
      19519258 Journal of child and adolescent psychopharmacology, 2009 June : 19(3)233-9 PMCID:PMC2856973
    • Gruber R, Joober R, Grizenko N, Leventhal BL, Cook EH Jr, Stein MA
      Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.
      19519258 Journal of child and adolescent psychopharmacology, 2009 June : 19(3)233-9 PMCID:PMC2856973
    • Polanczyk G, Faraone SV, Bau CH, Victor MM, Becker K, Pelz R, Buitelaar JK, Franke B, Kooij S, van der Meulen E, Cheon KA, Mick E, Purper-Ouakil D, Gorwood P, Stein MA, Cook EH Jr, Rohde LA
      The impact of individual and methodological factors in the variability of response to methylphenidate in ADHD pharmacogenetic studies from four different continents.
      18802923 American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2008 Dec. 5 : 147B(8)1419-24 PMCID:PMC2587514
    • Chronis-Tuscano A, Seymour KE, Stein MA, Jones HA, Jiles CD, Rooney ME, Conlon CJ, Efron LA, Wagner SA, Pian J, Robb AS
      Efficacy of osmotic-release oral system (OROS) methylphenidate for mothers with attention-deficit/hyperactivity disorder (ADHD): preliminary report of effects on ADHD symptoms and parenting.
      19192455 The Journal of clinical psychiatry, 2008 Dec. : 69(12)1938-47
    • Stein MA
      Medical mimics and differential diagnosis in adult ADHD.
      18955950 CNS spectrums, 2008 Oct. : 13(10 Suppl 1)14-6
    • Stein MA
      Treating adult ADHD with stimulants.
      18849904 CNS spectrums, 2008 Sept. : 13(9 Suppl 13)8-11
    • Phan L, Kasza K, Jalbrzikowski J, Noble AG, Latkany P, Kuo A, Mieler W, Meyers S, Rabiah P, Boyer K, Swisher C, Mets M, Roizen N, Cezar S, Sautter M, Remington J, Meier P, McLeod R, Toxoplasmosis Study Group
      Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life.
      18619570 American journal of ophthalmology, 2008 Sept. : 146(3)375-384 PMCID:PMC2747816
    • Shin DW, Stein MA
      Maternal depression predicts maternal use of corporal punishment in children with attention-deficit/hyperactivity disorder.
      18729299 Yonsei medical journal, 2008 Aug. 30 : 49(4)573-80 PMCID:PMC2615284
    • Stein MA
      Impairment associated with adult ADHD.
      18704030 CNS spectrums, 2008 Aug. : 13(8 Suppl 12)9-11
    • Benevento JD, Jager RD, Noble AG, Latkany P, Mieler WF, Sautter M, Meyers S, Mets M, Grassi MA, Rabiah P, Boyer K, Swisher C, McLeod R, Toxoplasmosis Study Group
      Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy.
      18695115 Archives of ophthalmology, 2008 Aug. : 126(8)1152-6 PMCID:PMC2741687
    • Stein MA, McGough JJ
      The pharmacogenomic era: promise for personalizing attention deficit hyperactivity disorder therapy.
      18295157 Child and adolescent psychiatric clinics of North America, 2008 April : 17(2)475-90, xi-xii PMCID:PMC2413066
    • Yang SJ, Shin DW, Noh KS, Stein MA
      Cortisol is inversely correlated with aggression for those boys with attention deficit hyperactivity disorder who retain their reactivity to stress.
      17582510 Psychiatry research, 2007 Sept. 30 : 153(1)55-60
    • Newcorn JH, Weiss M, Stein MA
      The complexity of ADHD: diagnosis and treatment of the adult patient with comorbidities.
      17667893 CNS spectrums, 2007 Aug. : 12(8 Suppl 12)1-14; quiz 15-6
    • Newcorn JH, Weiss M, Stein MA
      The complexity of ADHD: diagnosis and treatment of the adult patient with comorbidities.
      17667893 CNS spectrums, 2007 Aug. : 12(8 Suppl 12)1-14; quiz 15-6
    • Coccaro EF, Hirsch SL, Stein MA
      Plasma homovanillic acid correlates inversely with history of learning problems in healthy volunteer and personality disordered subjects.
      17113158 Psychiatry research, 2007 Jan. 15 : 149(1-3)297-302
    • Coccaro EF, Hirsch SL, Stein MA
      Plasma homovanillic acid correlates inversely with history of learning problems in healthy volunteer and personality disordered subjects.
      17113158 Psychiatry research, 2007 Jan. 15 : 149(1-3)297-302
    • Roizen N, Kasza K, Karrison T, Mets M, Noble AG, Boyer K, Swisher C, Meier P, Remington J, Jalbrzikowski J, McLeod R, Kipp M, Rabiah P, Chamot D, Estes R, Cezar S, Mack D, Pfiffner L, Stein M, Danis B, Patel D, Hopkins J, Holfels E, Stein L, Withers S, Cameron A, Perkins J, Heydemann P
      Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
      16864640 Pediatrics, 2006 Aug. : 118(2)e379-90
    • Roizen N, Kasza K, Karrison T, Mets M, Noble AG, Boyer K, Swisher C, Meier P, Remington J, Jalbrzikowski J, McLeod R, Kipp M, Rabiah P, Chamot D, Estes R, Cezar S, Mack D, Pfiffner L, Stein M, Danis B, Patel D, Hopkins J, Holfels E, Stein L, Withers S, Cameron A, Perkins J, Heydemann P
      Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
      16864640 Pediatrics, 2006 Aug. : 118(2)e379-90
    • McGough JJ, McBurnett K, Bukstein O, Wilens TE, Greenhill L, Lerner M, Stein M
      Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder.
      16768642 Journal of child and adolescent psychopharmacology, 2006 June : 16(3)351-6
    • Wilens TE, McBurnett K, Bukstein O, McGough J, Greenhill L, Lerner M, Stein MA, Conners CK, Duby J, Newcorn J, Bailey CE, Kratochvil CJ, Coury D, Casat C, Denisco MJ, Halstead P, Bloom L, Zimmerman BA, Gu J, Cooper KM, Lynch JM
      Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
      16389216 Archives of pediatrics & adolescent medicine, 2006 Jan. : 160(1)82-90
    • Mazei-Robison MS, Couch RS, Shelton RC, Stein MA, Blakely RD
      Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder.
      16171832 Neuropharmacology, 2005 Nov. : 49(6)724-36
    • Wilens T, McBurnett K, Stein M, Lerner M, Spencer T, Wolraich M
      ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study.
      16175106 Journal of the American Academy of Child and Adolescent Psychiatry, 2005 Oct. : 44(10)1015-23
    • Stein MA, Waldman ID, Sarampote CS, Seymour KE, Robb AS, Conlon C, Kim SJ, Cook EH
      Dopamine transporter genotype and methylphenidate dose response in children with ADHD.
      15827573 Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005 July : 30(7)1374-82
    • Stein MA
      Innovations in attention-deficit/hyperactivity disorder pharmacotherapy: long-acting stimulant and nonstimulant treatments.
      15352535 The American journal of managed care, 2004 July : 10(4 Suppl)S89-98
    • Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH
      A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.
      14595084 Pediatrics, 2003 Nov. : 112(5)e404
    • Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH
      A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.
      14595084 Pediatrics, 2003 Nov. : 112(5)e404
    • Stein MA, Weiss RE
      Thyroid function tests and neurocognitive functioning in children referred for attention deficit/hyperactivity disorder.
      12573298 Psychoneuroendocrinology, 2003 April : 28(3)304-16
    • Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, August G, Greenhill L, McBurnett K, Palumbo D, Swanson J, Wolraich M
      ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study.
      12649629 Journal of the American Academy of Child and Adolescent Psychiatry, 2003 April : 42(4)424-33
    • Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, August G, Greenhill L, McBurnett K, Palumbo D, Swanson J, Wolraich M
      ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study.
      12649629 Journal of the American Academy of Child and Adolescent Psychiatry, 2003 April : 42(4)424-33
    • Stein MA, Weiss RE
      Thyroid function tests and neurocognitive functioning in children referred for attention deficit/hyperactivity disorder.
      12573298 Psychoneuroendocrinology, 2003 April : 28(3)304-16
    • Hartung CM, Willcutt EG, Lahey BB, Pelham WE, Loney J, Stein MA, Keenan K
      Sex differences in young children who meet criteria for attention deficit hyperactivity disorder.
      12402565 Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53, 2002 Dec. : 31(4)453-64
    • Hartung CM, Willcutt EG, Lahey BB, Pelham WE, Loney J, Stein MA, Keenan K
      Sex differences in young children who meet criteria for attention deficit hyperactivity disorder.
      12402565 Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53, 2002 Dec. : 31(4)453-64
    • Sarampote CS, Efron LA, Robb AS, Pearl PL, Stein MA
      Can stimulant rebound mimic pediatric bipolar disorder?
      12014597 Journal of child and adolescent psychopharmacology, 2002 : 12(1)63-7
    • Sarampote CS, Efron LA, Robb AS, Pearl PL, Stein MA
      Can stimulant rebound mimic pediatric bipolar disorder?
      12014597 Journal of child and adolescent psychopharmacology, 2002 : 12(1)63-7
    • Stein, M.A., Szumowski, E., Blondis, T. & Roizen, N.
      Adaptive skills dysfunction in ADD and ADHD Children.
      Journal of Child Psychology and Psychiatry, 1995 : 36663-70
    • Stein, M. amd Weiss,M
      Sleep problems and interventions in preschoolers with ADHD
      ADHD in Preschool Children:Assessment and Treatment, 2013
    • Mark A. Stein, PhD, ABPP, Adler L, Spenccer T, and WIlens T
      Mimics of ADHD: Medical and Neurological.
      ADHD in Children, Adolescents and Adults.

  • Presentations Title Event Location Date
    Making Sense of ADHD Pharmacogenetics: DAT1, Ancestral Markers, Dose, and Study Methodology. SOciety of Biological Psychiatry San Francisco, Ca May 2013
    How new ADHD treatment studies can inform practice? WOrld Congress on ADHD Tel Aviv, Israel April 2013
    Stein M, White C, Enright G, Dammerman R. Morning or Evening Dosing of Guanfacine Extended Release: Remission of Pediatric ADHD as Assessed by Clinical Global Impressions. Pediatric Academic Society (Society for Pediatric Research Boston, MA. May 2012
    Pharmacogenomics and Personalized ADHD Treatment: Are we there yet? Johns Hoplins Spectrum Conference on ADHD Baltimore, MD April 2012
    Effects of Dosage on Sleep Duration during Stimulant Treatmenbt for ADHD Canadian Paediatric Society Montreal 2014
    Evaluating Research Start (Study and Trial Accelerator for Research Teams) NIH Workshop on Enrollment and Retention of Participants in Clinical TriaLS Bethesda,Maryland 2014

Overview

Board Certification(s)

Clinical Psychology

Medical/Professional School

Southern Illinois University at Carbondale, Carbondale, IL

Research Description

Dr. Stein's primary research interests include ADHD and its treatment. His current work explores the question: Can you improve how kids at risk for ADHD function by treating their parents first, with either medicine or parent training and exploring the sequencing of treatments? Through this work Dr. Stein hopes to improve the prognosis for young children at risk of ADHD due to genetics, as well as early onset behavior problems. Dr. Stein also conducts clinical trials of novel treatments targeting ADHD symptoms and associated impairments, including the relationship of ADHD and its treatment to sleep problems.